IMPACTS OF COVID-19 ON INDIVIDUALS WITH DOWN SYNDROME
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Scientia Generalis |
Texto Completo: | https://scientiageneralis.com.br/index.php/SG/article/view/382 |
Resumo: | Down Syndrome (DS) is a genetic disease that results in the presence of an extra 21st chromosome, which is why it is commonly called trisomy 21, this chromosomal abnormality may increase the risk of certain complications or may also present abnormalities that affect the pulmonary function, airway changes in DS patients can promote viral infections, which exacerbates the impact of Covid-19 in these patients. Therefore, this study aimed to present a deeper knowledge to the reader about how Covid-19 affects individuals with Down syndrome. This is an integrative literature review, whose data collection was carried out at the base: PubMed, in the period of May 2021 by crossing the following descriptors: Covid-19 and Down Syndrome (Down Syndrome). Articles from 2020 to 2021, with full text, in English, Portuguese or Spanish, were included in this review, and those that did not address the topic were excluded. Six studies concluded that Covid-19 patients with Down Syndrome (DS) are more likely to worsen the disease, with infections and longer hospital stays. Two studies also pointed to an increased risk of death from Covid-19 compared to people without DS. A study warned that patients with this profile should be considered at high risk for severe disease progression, in this case the child (4 months) was hospitalized and required oxygen support, being discharged after 10 days of hospitalization. Through the results, it is clear that Covid-19 has a negative and comprehensive impact on individuals with Down Syndrome, so that when they become ill, the clinical repercussions on these patients are too serious. |
id |
INDEP-1_f7c951f39fc62c2f2045a9f8d6762333 |
---|---|
oai_identifier_str |
oai:ojs2.scientiageneralis.com.br:article/382 |
network_acronym_str |
INDEP-1 |
network_name_str |
Scientia Generalis |
repository_id_str |
|
spelling |
IMPACTS OF COVID-19 ON INDIVIDUALS WITH DOWN SYNDROMEIMPACTOS DEL COVID-19 EN PERSONAS CON SÍNDROME DE DOWNIMPACTOS DA COVID-19 EM INDIVÍDUOS COM SÍNDROME DE DOWNsíndrome de DownDiscapacidad IntelectualCOVID-19Down syndromeIntellectual DisabilityCovid-19Síndrome de DownCovid-19Deficiência IntelectualDown Syndrome (DS) is a genetic disease that results in the presence of an extra 21st chromosome, which is why it is commonly called trisomy 21, this chromosomal abnormality may increase the risk of certain complications or may also present abnormalities that affect the pulmonary function, airway changes in DS patients can promote viral infections, which exacerbates the impact of Covid-19 in these patients. Therefore, this study aimed to present a deeper knowledge to the reader about how Covid-19 affects individuals with Down syndrome. This is an integrative literature review, whose data collection was carried out at the base: PubMed, in the period of May 2021 by crossing the following descriptors: Covid-19 and Down Syndrome (Down Syndrome). Articles from 2020 to 2021, with full text, in English, Portuguese or Spanish, were included in this review, and those that did not address the topic were excluded. Six studies concluded that Covid-19 patients with Down Syndrome (DS) are more likely to worsen the disease, with infections and longer hospital stays. Two studies also pointed to an increased risk of death from Covid-19 compared to people without DS. A study warned that patients with this profile should be considered at high risk for severe disease progression, in this case the child (4 months) was hospitalized and required oxygen support, being discharged after 10 days of hospitalization. Through the results, it is clear that Covid-19 has a negative and comprehensive impact on individuals with Down Syndrome, so that when they become ill, the clinical repercussions on these patients are too serious.El Síndrome de Down (SD) es una enfermedad genética que resulta en la presencia de un cromosoma 21 extra, por lo que comúnmente se le llama trisomía 21, esta anomalía cromosómica puede aumentar el riesgo de ciertas complicaciones o también puede presentar anomalías que afecten al pulmón. función, los cambios de las vías respiratorias en pacientes con SD pueden promover infecciones virales, lo que agrava el impacto de Covid-19 en estos pacientes. Por lo tanto, este estudio tuvo como objetivo presentar un conocimiento más profundo al lector sobre cómo Covid-19 afecta a las personas con síndrome de Down. Se trata de una revisión integradora de la literatura, cuya recogida de datos se realizó en la base: PubMed, en el periodo de mayo de 2021 cruzando los siguientes descriptores: Covid-19 y Síndrome de Down (Síndrome de Down). En esta revisión se incluyeron artículos de 2020 a 2021, con texto completo, en inglés, portugués o español, y se excluyeron aquellos que no abordaron el tema. Seis estudios concluyeron que los pacientes con Covid-19 con síndrome de Down (SD) tienen más probabilidades de empeorar la enfermedad, con infecciones y estadías hospitalarias más prolongadas. Dos estudios también señalaron un mayor riesgo de muerte por Covid-19 en comparación con las personas sin síndrome de Down. Un estudio advirtió que los pacientes con este perfil deben ser considerados de alto riesgo de progresión grave de la enfermedad, en este caso el niño (4 meses) fue hospitalizado y requirió soporte de oxígeno, siendo dado de alta a los 10 días de internación. A través de los resultados, queda claro que Covid-19 tiene un impacto negativo y global en las personas con Síndrome de Down, por lo que cuando se enferman, las repercusiones clínicas en estos pacientes son demasiado graves.A Síndrome de Down (SD) é uma condição genética que resulta na presença de um cromossomo 21 a mais, devido a isso é comumente chamada de trissomia 21, está anormalidade cromossômica pode aumentar o risco de certas complicações como também podem apresentar anormalidades que afetam a função pulmonar, as alterações das vias aéreas em pacientes com SD podem promover infecções virais, o que exacerba o impacto do vírus causador da Covid-19 nestes pacientes. Por isso, esse estudo objetivou a apresentação de um conhecimento mais profundo ao leitor sobre como o vírus causador da Covid-19 afeta os indivíduos com síndrome de Down. Trata-se de uma revisão integrativa da literatura, cujo levantamento de dados foi realizado na base: PubMed, no período de maio de 2021 mediante o cruzamento dos seguintes descritores: Covid-19 e Síndrome de Down (Down Syndrome). Foram incluídos nesta revisão artigos de 2020 a 2021, com texto completo, em Inglês, Português ou Espanhol, e excluídos aqueles que não abordavam o tema. Seis estudos chegaram à conclusão de que pacientes com Covid-19 com Síndrome de Down (SD) têm maiores chances de agravamento da doença, com infecções e maior hospitalização. Dois estudos apontaram também um maior risco de morte por Covid-19, em comparação a pessoas sem SD. Um estudo alertou que pacientes com esse perfil devem ser considerados de alto risco para progressão severa da doença, no caso em questão a criança (4 meses) foi internada e necessitou de suporte de oxigênio, recebendo alta após 10 dias de internação. Mediante os resultados, percebe-se que a Covid-19 impacta de forma negativa e abrangente os indivíduos com Síndrome de Down, de modo que ao ficarem doentes, as repercussões clínicas nesses pacientes são demasiadas grave.Scientia GeneralisScientia GeneralisScientia Generalis2022-03-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://scientiageneralis.com.br/index.php/SG/article/view/38227363/v3n1a13Scientia Generalis; v. 3 n. 1 (2022); 127-133Scientia Generalis; Vol. 3 No. 1 (2022); 127-133Scientia Generalis; Vol. 3 Núm. 1 (2022); 127-1332675-299927363/v3n1reponame:Scientia Generalisinstname:Publicação independenteinstacron:INDEPporhttps://scientiageneralis.com.br/index.php/SG/article/view/382/312Copyright (c) 2022 Isabella da Silva Figueredo Cintra, Larissa Naielly Souza Lima, Diego Silva Patríciohttps://creativecommons.org/licenses/by-sa/4.0info:eu-repo/semantics/openAccessda Silva Figueredo Cintra, IsabellaSouza Lima, Larissa NaiellySilva Patrício, Diego2023-08-01T03:32:15Zoai:ojs2.scientiageneralis.com.br:article/382Revistahttps://scientiageneralis.com.br/index.php/SGPRIhttps://scientiageneralis.com.br/index.php/SG/oaieditor@scientiageneralis.com.br2675-29992675-2999opendoar:2023-08-01T03:32:15Scientia Generalis - Publicação independentefalse |
dc.title.none.fl_str_mv |
IMPACTS OF COVID-19 ON INDIVIDUALS WITH DOWN SYNDROME IMPACTOS DEL COVID-19 EN PERSONAS CON SÍNDROME DE DOWN IMPACTOS DA COVID-19 EM INDIVÍDUOS COM SÍNDROME DE DOWN |
title |
IMPACTS OF COVID-19 ON INDIVIDUALS WITH DOWN SYNDROME |
spellingShingle |
IMPACTS OF COVID-19 ON INDIVIDUALS WITH DOWN SYNDROME da Silva Figueredo Cintra, Isabella síndrome de Down Discapacidad Intelectual COVID-19 Down syndrome Intellectual Disability Covid-19 Síndrome de Down Covid-19 Deficiência Intelectual |
title_short |
IMPACTS OF COVID-19 ON INDIVIDUALS WITH DOWN SYNDROME |
title_full |
IMPACTS OF COVID-19 ON INDIVIDUALS WITH DOWN SYNDROME |
title_fullStr |
IMPACTS OF COVID-19 ON INDIVIDUALS WITH DOWN SYNDROME |
title_full_unstemmed |
IMPACTS OF COVID-19 ON INDIVIDUALS WITH DOWN SYNDROME |
title_sort |
IMPACTS OF COVID-19 ON INDIVIDUALS WITH DOWN SYNDROME |
author |
da Silva Figueredo Cintra, Isabella |
author_facet |
da Silva Figueredo Cintra, Isabella Souza Lima, Larissa Naielly Silva Patrício, Diego |
author_role |
author |
author2 |
Souza Lima, Larissa Naielly Silva Patrício, Diego |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
da Silva Figueredo Cintra, Isabella Souza Lima, Larissa Naielly Silva Patrício, Diego |
dc.subject.por.fl_str_mv |
síndrome de Down Discapacidad Intelectual COVID-19 Down syndrome Intellectual Disability Covid-19 Síndrome de Down Covid-19 Deficiência Intelectual |
topic |
síndrome de Down Discapacidad Intelectual COVID-19 Down syndrome Intellectual Disability Covid-19 Síndrome de Down Covid-19 Deficiência Intelectual |
description |
Down Syndrome (DS) is a genetic disease that results in the presence of an extra 21st chromosome, which is why it is commonly called trisomy 21, this chromosomal abnormality may increase the risk of certain complications or may also present abnormalities that affect the pulmonary function, airway changes in DS patients can promote viral infections, which exacerbates the impact of Covid-19 in these patients. Therefore, this study aimed to present a deeper knowledge to the reader about how Covid-19 affects individuals with Down syndrome. This is an integrative literature review, whose data collection was carried out at the base: PubMed, in the period of May 2021 by crossing the following descriptors: Covid-19 and Down Syndrome (Down Syndrome). Articles from 2020 to 2021, with full text, in English, Portuguese or Spanish, were included in this review, and those that did not address the topic were excluded. Six studies concluded that Covid-19 patients with Down Syndrome (DS) are more likely to worsen the disease, with infections and longer hospital stays. Two studies also pointed to an increased risk of death from Covid-19 compared to people without DS. A study warned that patients with this profile should be considered at high risk for severe disease progression, in this case the child (4 months) was hospitalized and required oxygen support, being discharged after 10 days of hospitalization. Through the results, it is clear that Covid-19 has a negative and comprehensive impact on individuals with Down Syndrome, so that when they become ill, the clinical repercussions on these patients are too serious. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-03-11 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://scientiageneralis.com.br/index.php/SG/article/view/382 27363/v3n1a13 |
url |
https://scientiageneralis.com.br/index.php/SG/article/view/382 |
identifier_str_mv |
27363/v3n1a13 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://scientiageneralis.com.br/index.php/SG/article/view/382/312 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by-sa/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-sa/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Scientia Generalis Scientia Generalis Scientia Generalis |
publisher.none.fl_str_mv |
Scientia Generalis Scientia Generalis Scientia Generalis |
dc.source.none.fl_str_mv |
Scientia Generalis; v. 3 n. 1 (2022); 127-133 Scientia Generalis; Vol. 3 No. 1 (2022); 127-133 Scientia Generalis; Vol. 3 Núm. 1 (2022); 127-133 2675-2999 27363/v3n1 reponame:Scientia Generalis instname:Publicação independente instacron:INDEP |
instname_str |
Publicação independente |
instacron_str |
INDEP |
institution |
INDEP |
reponame_str |
Scientia Generalis |
collection |
Scientia Generalis |
repository.name.fl_str_mv |
Scientia Generalis - Publicação independente |
repository.mail.fl_str_mv |
editor@scientiageneralis.com.br |
_version_ |
1797042485781856256 |